Boston Scientific Announces Results For First Quarter 2021
News provided by
Share this article
Share this article
MARLBOROUGH, Mass., April 28, 2021 /PRNewswire/ Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.752 billion during the first quarter of 2021. This represents growth of 8.2 percent on a reported basis, 5.6 percent on an operational
1 basis and 5.9 percent on an organic
2 basis, all compared to the prior year period. The company reported GAAP net income available to common stockholders of $327 million or $0.23 per share (EPS), compared to GAAP net income of $11 million or $0.01 per share a year ago, and achieved adjusted EPS of $0.37 for the period, compared to $0.28 a year ago.
Global Electrophysiology Market Could Exceed $10 Billion By 2025 As Cardiovascular Devices Demand Grows
Financialnewsmedia.com News Commentary
PALM BEACH, Fla., Dec. 11, 2020 /PRNewswire/ The electrophysiology (EP) segment is poised to have substantial growth through 2025 and beyond according to various industry reports. Electrophysiology is the biomedical field that deals with the study of electric activity in the body. Electrophysiology includes the study of the generation of electrical activity and the effects of that electrical activity on the body. Certain factors that are driving the growth of the market are increasing prevalence of target diseases, technological advancements in the field of electrophysiology, and increasing demand for catheter ablation procedures. A recent report from MarketsAndMarkets projected that the global electrophysiology market is projected to reach USD 10.6 billion by 2025 from USD 6.8 billion in 2020, growing at a CAGR of 9.1% from 2020 to 2025.